NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
|
(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
|
|
|
IUPAC Traditional name
|
turmeric
|
curcumin
|
(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
|
|
|
Synonyms
|
Curcumin
|
Natural Yellow3
|
(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
|
(E,E)-1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
|
Diferulylmethane
|
Curcumin
|
Diferuloylmethane
|
C.I. 75300
|
Natural Yellow 3
|
Curcumin
|
Curcuminoid
|
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
|
Curcuma yellow
|
(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
|
C Yellow 15
|
C.I. Natural Yellow 3
|
Curcuma
|
Curcumin I
|
Curcumine
|
Haidr
|
Halad
|
Haldar
|
Ukon
|
姜黄素
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
Merck Index
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
CHEMBL
|
|
Chemspider ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
Color Index Number
|
|
E Number
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
9.061334
|
H Acceptors
|
6
|
H Donor
|
2
|
LogD (pH = 5.5)
|
4.124406
|
LogD (pH = 7.4)
|
4.1151395
|
Log P
|
4.1245246
|
Molar Refractivity
|
103.8106 cm3
|
Polarizability
|
38.873188 Å3
|
Polar Surface Area
|
93.06 Å2
|
Rotatable Bonds
|
8
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
InterBioScreen
Wikipedia
TRC
Sigma Aldrich
Toronto Research Chemicals -
C838500
|
A natural phenolic compound. Potent anti-tumor agent having anti-inflammatory and antioxidant properties. Induces apoptosis in cancer cells and inhibits phorbol ester-induced protein kinase C (PKC) activity. Reported to inhibit production of inflammatory |
Sigma Aldrich -
C1386
|
Biochem/physiol Actions A natural phenolic compound. Potent anti-tumor agent having anti-inflammatory and anti-oxidant properties. Curcumin has been cited as a potential chemopreventive agent, in addition to its chemotherapeutic activity.1 Induces apoptosis in cancer cells and inhibits phorbol ester-induced protein kinase C (PKC) activity. Reported to inhibit production of inflammatory cytokines by peripheral blood monocytes and alveolar macrophages. Potent inhibitor of EGFR tyrosine kinase and IκB kinase. Inhibits inducible nitric oxide synthase (iNOS), cycloxygenase and lipoxygenase. Easily penetrates into the cytoplasm of cells, accumulating in membranous structures such as plasma membrane, endoplasmic reticulum and nuclear envelope. |
Sigma Aldrich -
28260
|
Biochem/physiol Actions A natural phenolic compound. Potent anti-tumor agent having anti-inflammatory and anti-oxidant properties. Curcumin has been cited as a potential chemopreventive agent, in addition to its chemotherapeutic activity.1 Induces apoptosis in cancer cells and inhibits phorbol ester-induced protein kinase C (PKC) activity. Reported to inhibit production of inflammatory cytokines by peripheral blood monocytes and alveolar macrophages. Potent inhibitor of EGFR tyrosine kinase and IκB kinase. Inhibits inducible nitric oxide synthase (iNOS), cycloxygenase and lipoxygenase. Easily penetrates into the cytoplasm of cells, accumulating in membranous structures such as plasma membrane, endoplasmic reticulum and nuclear envelope. |
Sigma Aldrich -
08511
|
Biochem/physiol Actions A natural phenolic compound. Potent anti-tumor agent having anti-inflammatory and anti-oxidant properties. Curcumin has been cited as a potential chemopreventive agent, in addition to its chemotherapeutic activity.1 Induces apoptosis in cancer cells and inhibits phorbol ester-induced protein kinase C (PKC) activity. Reported to inhibit production of inflammatory cytokines by peripheral blood monocytes and alveolar macrophages. Potent inhibitor of EGFR tyrosine kinase and IκB kinase. Inhibits inducible nitric oxide synthase (iNOS), cycloxygenase and lipoxygenase. Easily penetrates into the cytoplasm of cells, accumulating in membranous structures such as plasma membrane, endoplasmic reticulum and nuclear envelope. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Srinivasan, et al.: J. Pharm. Pharmacol., 5, 448 (1953)
- • Tu, B., et al.: J .Cell Biol., 164, 341 (1953)
- • Xu, G., et al.: Biochemistry, 44, 9817 (1953)
- • Johnson, J., et al.: Cancer Lett., 255, 170 (1953)
- • Chem. and Eng. News 90(1953)
- • 44 (2012)
- • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 52C, (ir)
- • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 2, 800B, (nmr)
- • Lampe, V., Ber., 1918, 51, 1347, (synth)
- • Srinivasan, K.R., J. Pharm. Pharmacol., 1953, 5, 448, (derivs)
- • Spicer, G.S. et al., Anal. Chim. Acta, 1958, 18, 231, (detn, B)
- • Umland, F. et al., Fresenius' Z. Anal. Chem., 1963, 197, 151, (detn, Ni)
- • Jentzsch, K. et al., Sci. Pharm., 1968, 36, 251; CA, 70, 90793h, (isol)
- • Sastry, B.S., Res. Ind., 1970, 15, 258; CA, 75, 75063e, (isol)
- • Kuroyagi, M. et al., Yakugaku Zasshi, 1970, 90, 1467; CA, 74, 61612a, (isol)
- • Dyrssen, D.W. et al., Anal. Chim. Acta, 1972, 60, 139, (detn, B)
- • Roughley, P.J. et al., J.C.S. Perkin 1, 1973, 2379-2388, (biosynth)
- • Karig, F., Dtsch. Apoth. -Ztg., 1975, 115, 325; CA, 83, 65372f, (derivs)
- • Quint, P. et al., Fresenius' Z. Anal. Chem., 1977, 285, 356; 1979, 295, 269, (detn, B)
- • Kashina, C. et al., Heterocycles, 1977, 7, 241, (synth)
- • Wahlstrom, B. et al., Acta Pharmacol. Toxicol., 1978, 43, 86, (metab)
- • Holder, G.M. et al., Xenobiotica, 1978, 8, 761, (metab)
- • Tonnesen, H.H. et al., Acta Chem. Scand., Ser. B, 1982, 36, 475, (cryst struct, bibl)
- • Cheng, K.L. et al., Handbook of Organic Analytical Reagents, CRC Press, Boca Raton, 1982, 511, (use)
- • Ammon, H.P.T. et al., Planta Med., 1991, 57, 1-7, (rev, pharmacol)
- • Jitoe, A. et al., J. Agric. Food Chem., 1992, 40, 1337-1340, (occur)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent